Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Has ceritinib patent expired in europe?

See the DrugPatentWatch profile for ceritinib

Has ceritinib’s patent protection expired in Europe?

The information provided here does not say whether ceritinib’s (Zykadia) patents have expired in Europe. Patent and exclusivity status depends on the specific patent family, whether there are supplementary protection certificates (SPCs), and what date each right expires in each country.

What typically determines whether ceritinib is still protected in Europe?

Even if a “basic” patent term ends, generic and biosimilar competition in Europe can be delayed by:
- Supplementary protection certificates (SPCs), which can extend protection for active ingredients beyond the original patent term.
- Separate patents covering formulations, manufacturing processes, or specific uses, which can run for different periods.
- Marketing-authorisation/clinical-data exclusivity rules (distinct from patent term).

How can you check the exact expiry date for ceritinib in Europe?

To determine whether ceritinib’s patent protection has expired for EU countries, you usually need to check:
- The specific European patent (or application) number(s) covering ceritinib.
- Whether an SPC was filed/granted for the product in the relevant EU member states.
- The expiry dates listed in national patent/SPC registers.

If you share any of the following, I can help you pinpoint the right expiry dates: the relevant patent number(s) (EP…), the brand name (Zykadia), and/or the country (e.g., UK vs EU member states).

Is the UK treated the same as “Europe” for patent expiry?

Not exactly. The UK left the EU, so “Europe” can mean different things for protection status:
- Some rights and registers are UK-specific after Brexit.
- SPC and enforcement details may differ from EU member states.

Quick clarification that affects the answer

When people ask whether a drug’s patent has “expired,” they may mean:
- the first patent in the family is over,
- all key patents are over,
- or the last exploitable exclusivity/SPC has ended (which is what generally blocks generics).

Tell me which meaning you care about (and which country: UK or specific EU state), and I’ll guide you to the correct way to verify expiry.



Other Questions About Ceritinib :

ceritinib patent expiry application no. of novartis patent for ceritinib/ ceritinib accelerated approval withdrawn federal register 2023